Proven effective in clinical testing, the ED1000 is a unique mobile system that performs the EDSWT protocol in a safe, efficient manner. Vasculogenic and diabetic ED patients, who are responsive to PDE5 inhibitors as well as those who are unresponsive, can receive shock wave therapy from the ED1000 and experience improved erectile functionality. The system is available in two models, ED1000 and ED1000 Desktop.
Unlike conventional ED treatment, such as PDE5 inhibitors, EDSWT does not involve the use of any pharmaceuticals. Moreover, the shock wave treatment causes no side-effects or systemic load on other organs and healthy tissues. The non-invasive, painless EDSWT procedure is performed during a series of brief visits at the clinic, and requires no sedation or anesthesia. Discernable improvement in the erectile function of the penis can be visible within two weeks after therapy begins. Recent clinical studies revealed that patients reported a high rate of satisfaction for more than two years after treatment – all without reliance on PDE5 inhibitors. In clinical tests, EDSWT has shown significant long-term effectiveness. These results are confirmed by a double-blind placebo controlled study of a large group of patients.
